Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Patient-centered disease management (PCDM) for heart failure: study protocol for a randomised controlled trial BMC CARDIOVASCULAR DISORDERS Bekelman, D. B., Plomondon, M. E., Sullivan, M. D., Nelson, K., Hattler, B., McBryde, C., Lehmann, K. G., Potfay, J., Heidenreich, P., Rumsfeld, J. S. 2013; 13

Abstract

Chronic heart failure (HF) disease management programs have reported inconsistent results and have not included comorbid depression management or specifically focused on improving patient-reported outcomes. The Patient Centered Disease Management (PCDM) trial was designed to test the effectiveness of collaborative care disease management in improving health status (symptoms, functioning, and quality of life) in patients with HF who reported poor HF-specific health status.Patients with a HF diagnosis at four VA Medical Centers were identified through population-based sampling. Patients with a Kansas City Cardiomyopathy Questionnaire (KCCQ, a measure of HF-specific health status) score of?

View details for DOI 10.1186/1471-2261-13-49

View details for Web of Science ID 000322037600001

View details for PubMedID 23837415

View details for PubMedCentralID PMC3718720